Bausch Health Cos., Inc. (BHC)
6.02
+0.09
(+1.52%)
USD |
NYSE |
Feb 20, 10:34
Bausch Health Cos. EPS Diluted (Quarterly) : -0.3023 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.2819 |
| Lexaria Bioscience Corp. | -0.0746 |
| Xenon Pharmaceuticals, Inc. | -1.147 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -103.00M |
| Revenue (Quarterly) | 2.796B |
| Total Expenses (Quarterly) | 2.908B |
| Enterprise Value | 22.88B |
| Gross Profit Margin (Quarterly) | 63.02% |
| Profit Margin (Quarterly) | -3.68% |
| Earnings Yield | 6.88% |
| Operating Earnings Yield | 97.52% |
| Normalized Earnings Yield | 13.34 |